Patent ID: 8912236
Filing Date: 2014-12-16
Classification: A61K,A61P,Y10S

Abstract:
1. A method for treating age-related macular degeneration in a patient in need thereof with a therapeautically effective amount of a multi-targeted receptor tyrosine kinase inhibitor comprising: heating an ophthalmic composition to its melting point to liquefy the ophthalmic composition, the ophthalmic composition comprising the multi-targeted receptor tyrosine kinase inhibitor in an amount of from 0.01% to 20% and polyethylene glycol having a molecular weight of at least 6000 in an amount from 40% to 98%; injecting into an eye of the patient the ophthalmic composition in liquid form after heating; and allowing the composition to cool in the eye of the patient causing the composition to solidify in the eye of the patient.